Bots, editor, reviewer, Administrators
13,951
edits
WikiJournalClub:Usable articles: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 22: | Line 22: | ||
* [[MADIT-II]] (2002): ICD in post-MI patients with HFrEF | * [[MADIT-II]] (2002): ICD in post-MI patients with HFrEF | ||
* [[MIRACL]] (2001): Atorvastatin in UA/NSTEMI | * [[MIRACL]] (2001): Atorvastatin in UA/NSTEMI | ||
* [[OAT]] (2006): PCI+OMT vs. OMT 3-28 days after MI | |||
* [[PEGASUS-TIMI 54]] (2015): Extended ticagrelor+ASA after MI | * [[PEGASUS-TIMI 54]] (2015): Extended ticagrelor+ASA after MI | ||
* [[PLATO]] (2009): Ticagrelor vs. clopidogrel in ACS | * [[PLATO]] (2009): Ticagrelor vs. clopidogrel in ACS | ||
| Line 91: | Line 92: | ||
* [[LoDoCo]] (2013): Colchicine for stable CAD | * [[LoDoCo]] (2013): Colchicine for stable CAD | ||
* [[MIRACL]] (2001): Atorvastatin in UA/NSTEMI | * [[MIRACL]] (2001): Atorvastatin in UA/NSTEMI | ||
* [[OAT]] (2006): PCI+OMT vs. OMT 3-28 days after MI | |||
* [[ORIGIN n-3 Fatty Acids]] (2012): Fish oil for high-risk CVD | * [[ORIGIN n-3 Fatty Acids]] (2012): Fish oil for high-risk CVD | ||
* [[PEGASUS-TIMI 54]] (2015): Extended ticagrelor+ASA after MI | * [[PEGASUS-TIMI 54]] (2015): Extended ticagrelor+ASA after MI | ||
| Line 185: | Line 187: | ||
* [[ISIS-2]] (1988): Aspirin ± streptokinase in acute MI | * [[ISIS-2]] (1988): Aspirin ± streptokinase in acute MI | ||
* [[MADIT-II]] (2002): ICD in post-MI patients with HFrEF | * [[MADIT-II]] (2002): ICD in post-MI patients with HFrEF | ||
* [[OAT]] (2006): PCI+OMT vs. OMT 3-28 days after MI | |||
* [[PEGASUS-TIMI 54]] (2015): Extended ticagrelor+ASA after MI | * [[PEGASUS-TIMI 54]] (2015): Extended ticagrelor+ASA after MI | ||
* [[PRAMI]] (2013): PCI to high-risk non-infarct arteries in STEMI | * [[PRAMI]] (2013): PCI to high-risk non-infarct arteries in STEMI | ||